2015年至2018年CFDA臨床試驗(yàn)信息（包括新藥、BE、醫(yī)療器械等）   [更多]

1.文章名稱： (1).Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Kawate H, Takayanagi R.Clin Interv Aging. 2011;6:151-60. Epub 2011 Jun 21. Review. (2).J Vasc Surg. 2017 May 19. pii: S0741-5214(17)30915-1. Medical management of claudication. Ratchford EV. (3). Neuropsychiatr Dis Treat. 2017 May 11;13:1281-1302. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Kishi T, Ikuta T, Matsunaga S, Matsuda Y1,, Oya K, Iwata N. (4). BMJ Case Rep. 2017 May 9;2017. pii: bcr-2017-219929. Aripiprazole-induced hypersensitivity pneumonitis. Gunasekaran K, Murthi S, Jennings J, Lone N. (5). Curr Neuropharmacol. 2017 Apr 13. Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity. Tuplin EW1, Holahan MR. (6). Expert Opin Pharmacother. 2017 Feb;18(2):217-223. Brexpiprazole for the treatment of schizophrenia. Hsu WY, Lane HY, Lin CH. (7). J Clin Psychiatry. 2015 Sep;76(9):1232-40. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study. Thase ME1, Youakim JM, Skuban A, Hobart M, Zhang P, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H. (8). Ter Arkh. 2017;89(4):101-109. New opportunities for the prevention of gastric cancer. Maev IG, Kazyulin AN. (9). Oral Dis. 2017 May;23(4):511-517. Rebamipide, an anti-ulcerative drug, inhibits induction of salivary dysfunction by benzodiazepines. Ogane M, Okubo M, Yoshikawa M, Shinomiya T, Tsukagoshi E, Kawaguchi M. (10).、Int J Clin Pharm. 2017 May 29.Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.Huang JJ, Chen B, Hu J. 2.需要下載到文獻(xiàn)全文的PDF版本，以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]

用于生產(chǎn)研究。   [更多]

1.文章名稱： （1）Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.M. Biswas (1), G. L. Rogers (1), A. Sherman (1), B. J. Byrne (1), D. M. Markusic (1), H. Jiang (2), R. W. Herzog (1).University of Florida, Department of Pediatrics, Division of Cellular and Molecular Therapy, Gainesville, Florida, USA; (2) Biogen, Cambridge, Massachusetts, USA. 2.需要下載到文獻(xiàn)全文的PDF版本，以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]

求助注射用鹽酸丙帕他莫的原研廠家信息及說(shuō)明書(shū)   [更多]

1.文章名稱： （1）Determination of trace bismuth by atomic fluorescence spectrometry in blood Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2016 Dec 20;34(12):939-941. （2）Bismuth concentration in blood and urine of children treated with ventrisol (polfa) preliminary study. Iwańczak F , Rajska H , Iwańczak B , Górecka H Roczniki Akademii Medycznej w Bialymstoku (1995) [01 Jan 1995, 40(3):685-691]. 2.需要下載到文獻(xiàn)全文的PDF版本，以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序，先到先得，一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]

磷酸奧司他韋膠囊 標(biāo)準(zhǔn)號(hào)：JX20000198 標(biāo)準(zhǔn)號(hào)：YBH10932004 最好能提供費(fèi)用發(fā)票   [更多]

需要看這兩個(gè)產(chǎn)品的使用說(shuō)明書(shū)及作用方式，請(qǐng)求大家分享下。若還有同類(lèi)產(chǎn)品其他方面的文件，采納后另算   [更多]

合作方式：1.一次性轉(zhuǎn)讓并提供后續(xù)技術(shù)指導(dǎo)和支持。 2技術(shù)入股.成立合資公司。 3共同經(jīng)營(yíng).或其他合作方式。   [更多]

藥復(fù)核標(biāo)準(zhǔn)匯編（2003）P1032藥復(fù)核標(biāo)準(zhǔn)匯編（1999）P427   [更多]